secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001297184-24-000042
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar board authorizes $50M increase to share buyback program to offset dilution
--------------------------------------------------------------------------------

- $50M increase to buyback program authorized June 3, 2024; program continues indefinitely.
- Primary goal is to offset dilution from equity compensation programs.
- Purchases may be via open market, block trades, Rule 10b5-1 plans, or negotiated transactions.
- Timing and number of shares repurchased depend on price, corporate and regulatory factors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718424000042/0001297184-24-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718424000042/amph-20240603x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-24-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer